Latacz, P.; Popiela, T.; Brzegowy, P.; Lasocha, B.; Kwiecień, K.; Simka, M.
Correction: Latacz et al. Safety and Efficacy of Low-Dose Eptifibatide for Tandem Occlusions in Acute Ischemic Stroke. Neurol. Int. 2024, 16, 253–262. Neurol. Int. 2025, 17, 90.
https://doi.org/10.3390/neurolint17060090
AMA Style
Latacz P, Popiela T, Brzegowy P, Lasocha B, Kwiecień K, Simka M.
Correction: Latacz et al. Safety and Efficacy of Low-Dose Eptifibatide for Tandem Occlusions in Acute Ischemic Stroke. Neurol. Int. 2024, 16, 253–262. Neurology International. 2025; 17(6):90.
https://doi.org/10.3390/neurolint17060090
Chicago/Turabian Style
Latacz, Paweł, Tadeusz Popiela, Paweł Brzegowy, Bartłomiej Lasocha, Krzysztof Kwiecień, and Marian Simka.
2025. "Correction: Latacz et al. Safety and Efficacy of Low-Dose Eptifibatide for Tandem Occlusions in Acute Ischemic Stroke. Neurol. Int. 2024, 16, 253–262" Neurology International 17, no. 6: 90.
https://doi.org/10.3390/neurolint17060090
APA Style
Latacz, P., Popiela, T., Brzegowy, P., Lasocha, B., Kwiecień, K., & Simka, M.
(2025). Correction: Latacz et al. Safety and Efficacy of Low-Dose Eptifibatide for Tandem Occlusions in Acute Ischemic Stroke. Neurol. Int. 2024, 16, 253–262. Neurology International, 17(6), 90.
https://doi.org/10.3390/neurolint17060090